Scinai Immunotherapeutics (SCNI) vs Valion Bio (VBIO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Valion Bio is the larger company by market cap ($2.0 million vs $1.6 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | SCNI | VBIO |
|---|---|---|
| Share price | $1.21 | $2.21 |
| Market cap | $1.64M | $1.96M |
| 1-day change | +7.08% | +0.91% |
| P/E ratio (TTM) | 0.04 | — |
| EPS (TTM) | $28.07 | $-177.91 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $15.65 | $76.50 |
| 52-week low | $1.06 | $2.05 |
| Distance from 52-week high | -92.27% | -97.11% |
| Average volume | 1.10M | 1.46M |
| Shares outstanding | 1.35M | 887.59K |
| Employees | 45 | 52 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Scinai Immunotherapeutics
SCNI stock →Scinai Immunotherapeutics Ltd., together with its subsidiaries, operates as a biopharmaceutical company in Israel and internationally. It engages in the research and development of IL-17 NanoAb, a VHH-based antibody platform for the treatment of immune-mediated and inflammatory diseases, including psoriasis; and PC111, a human monoclonal antibody for the treatment of pemphigus, Steven Johnson's syndrome, and toxic epidermal necrolysis.
Healthcare · Biotechnology · 45 employees
About Valion Bio
VBIO stock →Valion Bio, Inc. operates as a late-stage biopharmaceutical company.
Healthcare · Biotechnology · 52 employees
SCNI vs VBIO FAQ
Which is bigger, Scinai Immunotherapeutics or Valion Bio?
Valion Bio (VBIO) is larger, with a market capitalization of $1.96M compared with $1.64M for Scinai Immunotherapeutics (SCNI).
Are Scinai Immunotherapeutics and Valion Bio in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.